Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 12.114 Q1 | 254 | 36 | 91 | 13930 | 2347 | 91 | 20.90 | 386.94 | 23.02 | |
2 | Medicinal Research Reviews | journal | 2.746 Q1 | 150 | 35 | 87 | 7834 | 749 | 85 | 8.31 | 223.83 | 26.28 | |
3 | Issues in Toxicology | book series | 0.160 Q4 | 18 | 40 | 122 | 8309 | 50 | 114 | 0.27 | 207.73 | 34.78 | |
4 | Pharmacology and Therapeutics | journal | 3.622 Q1 | 233 | 105 | 312 | 21154 | 3026 | 311 | 9.21 | 201.47 | 30.20 | |
5 | Reviews of Physiology Biochemistry and Pharmacology | journal | 1.754 Q1 | 70 | 5 | 10 | 931 | 41 | 10 | 4.10 | 186.20 | 6.25 | |
6 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.920 Q2 | 82 | 15 | 34 | 2655 | 135 | 34 | 4.26 | 177.00 | 36.00 | |
7 | Journal of Experimental Pharmacology | journal | 0.129 Q4 | 23 | 1 | 3 | 166 | 2 | 3 | 0.50 | 166.00 | 100.00 | |
8 | Journal of Receptor, Ligand and Channel Research | journal | 0.481 Q3 | 13 | 2 | 12 | 279 | 23 | 11 | 0.43 | 139.50 | 33.33 | |
9 | Advances in Molecular Toxicology | book series | 0.371 Q3 | 18 | 7 | 23 | 939 | 34 | 6 | 1.20 | 134.14 | 0.00 | |
10 | Annual Review of Pharmacology and Toxicology | journal | 10.782 Q1 | 224 | 27 | 61 | 3273 | 1517 | 61 | 21.39 | 121.22 | 24.32 | |
11 | Cellular and Molecular Life Sciences | journal | 3.339 Q1 | 261 | 301 | 893 | 36153 | 5840 | 887 | 6.40 | 120.11 | 41.59 | |
12 | Drug Resistance Updates | journal | 3.734 Q1 | 132 | 10 | 72 | 1170 | 828 | 67 | 10.58 | 117.00 | 34.88 | |
13 | Current Drug Metabolism | journal | 1.138 Q1 | 122 | 100 | 302 | 10414 | 1284 | 266 | 3.59 | 104.14 | 43.23 | |
14 | Journal of Applied Research | journal | 0.148 Q4 | 23 | 2 | 40 | 203 | 14 | 39 | 0.17 | 101.50 | 44.44 | |
15 | Vaccines | journal | 85 | 2 | 0 | 202 | 0 | 0 | 0.00 | 101.00 | 33.33 | ||
16 | Advances in Pharmacology | journal | 2.633 Q1 | 86 | 40 | 106 | 3814 | 517 | 1 | 5.30 | 95.35 | 0.00 | |
17 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.199 Q3 | 29 | 12 | 34 | 1144 | 19 | 0 | 0.58 | 95.33 | 0.00 | |
18 | Expert Opinion on Emerging Drugs | journal | 0.951 Q2 | 54 | 40 | 136 | 3787 | 434 | 134 | 3.44 | 94.68 | 37.98 | |
19 | Neurotherapeutics | journal | 2.471 Q1 | 136 | 71 | 188 | 6671 | 1188 | 174 | 4.48 | 93.96 | 38.18 | |
20 | Progress in Medicinal Chemistry | journal | 0.983 Q2 | 38 | 6 | 17 | 543 | 50 | 1 | 3.55 | 90.50 | 0.00 | |
21 | Expert Opinion on Therapeutic Targets | journal | 2.023 Q1 | 106 | 130 | 359 | 11733 | 1726 | 355 | 4.86 | 90.25 | 36.19 | |
22 | Expert Opinion on Therapeutic Patents | journal | 1.188 Q1 | 88 | 112 | 330 | 9802 | 1165 | 324 | 3.50 | 87.52 | 31.87 | |
23 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 128 | 368 | 11082 | 1279 | 366 | 3.49 | 86.58 | 36.88 | |
24 | Clinical Medicine Insights: Therapeutics | journal | 0.117 Q4 | 11 | 13 | 105 | 1049 | 31 | 105 | 0.32 | 80.69 | 35.14 | |
25 | Expert Opinion on Investigational Drugs | journal | 1.489 Q1 | 117 | 139 | 452 | 10890 | 1969 | 440 | 4.39 | 78.35 | 29.82 | |
26 | Journal of NeuroImmune Pharmacology | journal | 1.264 Q1 | 91 | 109 | 212 | 8448 | 726 | 201 | 2.79 | 77.50 | 44.66 | |
27 | Therapeutic Advances in Neurological Disorders | journal | 1.144 Q1 | 68 | 31 | 88 | 2319 | 397 | 86 | 4.82 | 74.81 | 48.65 | |
28 | Molecular Diagnosis and Therapy | journal | 0.759 Q2 | 68 | 36 | 112 | 2679 | 256 | 105 | 2.41 | 74.42 | 38.79 | |
29 | Expert Opinion on Biological Therapy | journal | 1.288 Q1 | 102 | 163 | 471 | 12106 | 1906 | 462 | 3.98 | 74.27 | 31.58 | |
30 | Altex | journal | 0.841 Q2 | 64 | 39 | 102 | 2875 | 293 | 81 | 2.78 | 73.72 | 43.32 | |
31 | Frontiers in Pharmacology | journal | 1.352 Q1 | 154 | 150 | 335 | 11057 | 1197 | 329 | 3.70 | 73.71 | 43.46 | |
32 | BioDrugs | journal | 0.871 Q2 | 79 | 56 | 137 | 4080 | 452 | 134 | 2.69 | 72.86 | 45.45 | |
33 | Pharmacological Research | journal | 1.702 Q1 | 169 | 128 | 433 | 9193 | 2275 | 421 | 4.58 | 71.82 | 48.28 | |
34 | Neuropharmacology | journal | 2.428 Q1 | 191 | 435 | 956 | 31006 | 4802 | 939 | 5.11 | 71.28 | 41.15 | |
35 | Expert Review of Vaccines | journal | 1.381 Q1 | 105 | 142 | 459 | 10084 | 1679 | 380 | 3.54 | 71.01 | 38.21 | |
36 | Clinical Pharmacokinetics | journal | 2.140 Q1 | 184 | 78 | 175 | 5515 | 1295 | 165 | 6.14 | 70.71 | 31.59 | |
37 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.752 Q1 | 150 | 240 | 783 | 16667 | 3083 | 648 | 4.37 | 69.45 | 41.68 | |
38 | Journal of International Peacekeeping | journal | 0.333 Q3 | 14 | 17 | 50 | 1160 | 28 | 49 | 0.69 | 68.24 | 29.41 | |
39 | Inflammopharmacology | journal | 0.795 Q2 | 68 | 41 | 102 | 2796 | 288 | 96 | 3.33 | 68.20 | 34.45 | |
40 | British Journal of Pharmacology | journal | 2.283 Q1 | 244 | 435 | 1515 | 29528 | 8167 | 1459 | 5.20 | 67.88 | 39.54 | |
41 | Expert Opinion on Pharmacotherapy | journal | 0.793 Q2 | 93 | 240 | 792 | 15993 | 2113 | 752 | 2.72 | 66.64 | 35.28 | |
42 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.624 Q2 | 88 | 56 | 140 | 3727 | 381 | 140 | 2.28 | 66.55 | 39.22 | |
43 | Trends in Pharmacological Sciences | journal | 5.425 Q1 | 244 | 92 | 256 | 5973 | 2800 | 240 | 10.36 | 64.92 | 33.33 | |
44 | Antiviral Chemistry and Chemotherapy | journal | 0.801 Q2 | 59 | 7 | 63 | 451 | 175 | 61 | 2.40 | 64.43 | 20.00 | |
45 | Prostaglandins and Other Lipid Mediators | journal | 1.082 Q1 | 86 | 57 | 148 | 3661 | 445 | 144 | 3.12 | 64.23 | 38.06 | |
46 | Core Evidence (discontinued) | journal | 0.685 Q2 | 29 | 7 | 29 | 442 | 82 | 28 | 3.63 | 63.14 | 15.79 | |
47 | Vascular Pharmacology | journal | 1.368 Q1 | 108 | 69 | 178 | 4339 | 776 | 165 | 4.88 | 62.88 | 40.56 | |
48 | Pharmacogenomics and Personalized Medicine | journal | 0.572 Q2 | 37 | 16 | 33 | 996 | 73 | 33 | 2.68 | 62.25 | 55.17 | |
49 | Journal of Psychopharmacology | journal | 1.592 Q1 | 135 | 129 | 573 | 8018 | 2123 | 541 | 3.71 | 62.16 | 38.82 | |
50 | Drug Discovery Today | journal | 2.020 Q1 | 215 | 159 | 449 | 9878 | 3042 | 408 | 6.23 | 62.13 | 29.65 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®